Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-488303.00.
ENTERPRISE VALUE (EV)
$-488303.00
KALA BIO, Inc.
Market Cap
$7.07M
Enterprise Value (EV)
$-488303.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| KALA BIO, Inc. (KALA) | $7.07M | $-488303.00 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | $7.02M |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | $7.08M |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.23M | $4.56M |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | $5.11M |
| Longeveron Inc. (LGVN)vs › | $7.33M | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.80M | $15.57M |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.42M | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.66M | $4.81M |
Market Cap
$7.07M
Total Debt
$0.00
Cash
$7.56M
Enterprise Value
$-488303.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
